Navigation Links
Bayer CropScience Debuts Serenade Optimum to Help Growers Control Tough Diseases and Combat Resistance
Date:10/21/2013

Reno, Nev. (PRWEB) October 21, 2013

Today during the 39th Annual CAPCA Conference, Bayer CropScience introduced Serenade® Optimum fungicide and bactericide, its newest innovation for horticulture growers. An excellent addition to a complex disease management program, Serenade Optimum gives growers a new tool to help win the battle against fungal and bacterial diseases while fighting resistance.

“As a global market leader in crop protection, we continuously invest in innovations for new technologies that improve the health, quality and yield of horticulture crops,” said Rob Schrick, Strategic Business Management Lead – Horticulture, Bayer CropScience. “With the addition of Serenade Optimum, we further our commitment to delivering innovative solutions that aid growers in producing quality crops.”

Based on a unique patented strain of Bacillus subtilis (QST 713), Serenade Optimum works in multiple ways to provide effective contact control or suppression of problematic fungal and bacterial diseases. The fungicide’s novel, multi-site mode-of-action makes it very difficult for diseases to develop resistance, empowering growers with a new tool to combat fungicide resistance and enhance existing integrated disease management programs.

Serenade Optimum has a four-hour re-entry internal, a zero-day pre-harvest interval, and is exempt from the requirements of residue tolerance. It is part of a collection of biological fungicides and insecticides from Bayer CropScience that give growers more options in their integrated disease management programs to help fight resistance and optimize the marketability of their crops.

Serenade Optimum is available for use on grapes, leafy and fruiting vegetables, strawberries and potatoes, and is highly effective against fungal diseases, such as Botrytis and Sclerotinia, and bacterial diseases, such as Xanthomonas and Erwinia.

To learn more about Serenade Optimum please visit http://www.bayercropscience.us/products/fungicides/serenade-optimum/. You can also follow and share with us on Twitter @Bayer4CropsUS or connect on the Bayer CropScience social media hub, Bayer Connect.

© 2013 Bayer CropScience LP, 2 T.W. Alexander Drive, Research Triangle Park, NC 27709. Always read and follow label instructions. Bayer, the Bayer Cross and Serenade are registered trademarks of Bayer. For product information call toll-free 1-866-99-BAYER (1-866-992-2937) or visit our Website at bayercropscience.com.

###

About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care,
agriculture and high-tech materials. This year the company looks back on 150 years of working to fulfill its mission “Bayer: Science For A Better Life”. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,383 million (2012) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 20,800 and is represented in more than 120 countries. This and further news is available at: press.bayercropscience.com.

Contact:
Bayer CropScience Media Hotline, 1-877-879-6162, or

Becca Hogan
External Communications Manager
Bayer CropScience
Tel: (919) 549-2998
Email: becca(dot)hogan(at)bayer(dot)com

Ayanna Luke
Porter Novelli
Tel: (404) 995-4536
Email: ayanna(dot)luke(at)porternovelli(dot)com

USA-BCS-2013-0291
Find more information at bayercropscience.us.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11247555.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Bayer CropScience Supports 10th Anniversary of United Way Of The Greater Triangle’s Girls’ Leadership Development Initiative
2. Bayer CropScience and the Florida Specialty Crop Foundation Join Together to Fight Citrus Greening
3. Bayer CropScience Adds Three New HBK Seed Varieties for 2014
4. Bayer CropScience Looks to the Future of Farming at 2013 Farm Progress Show
5. Bayer CropScience Commits to Future of Illinois Agriculture, Education and Communities
6. Bayer CropScience and MS Technologies Receive Approval for Balance GT Soybean Technology in the United States
7. Bayer CropScience Adds New Canola Hybrids and Traits
8. American Museum of Agriculture Changes Name to Reflect Bayer CropScience’s Agriculture Tradition and World-Class Technology
9. Bayer CropScience Sponsors U.S. Delegates at Inaugural Global Youth Ag Summit
10. Bayer CropScience Celebrates 150 Years of Innovation; Asks for 150 Perspectives on the Future of Farming
11. Bayer CropScience Presents on Bee Health and Stewardship at International Pollinator Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... STACS DNA Inc., ... Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field ... DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
Breaking Biology News(10 mins):